Medicover AB (publ) (FRA:5M0B)
Germany · Delayed Price · Currency is EUR 19.34
-0.16 (-0.82%)
At close: Jan 30, 2026
Medicover AB Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 2,322 | 2,092 | 1,746 | 1,510 | 1,377 | 997.8 | |
Revenue Growth (YoY) | 16.23% | 19.78% | 15.64% | 9.64% | 38.04% | 18.17% |
Cost of Revenue | 1,788 | 1,644 | 1,387 | 1,170 | 982.4 | 733.6 |
Gross Profit | 534.3 | 448.3 | 359.4 | 340.1 | 395 | 264.2 |
Selling, General & Admin | 371.2 | 375.1 | 297.5 | 271.4 | 232.4 | 196.2 |
Operating Expenses | 371.2 | 375.1 | 297.5 | 271.4 | 232.4 | 196.2 |
Operating Income | 163.1 | 73.2 | 61.9 | 68.7 | 162.6 | 68 |
Interest Expense | -63.1 | -58.8 | -51.4 | -34.5 | -20.1 | -18.1 |
Interest & Investment Income | 4.4 | 4.8 | 4.4 | 2.7 | 1 | 0.9 |
Earnings From Equity Investments | 0.2 | - | 0.1 | 0.2 | 1 | 0.1 |
Currency Exchange Gain (Loss) | 0.8 | 3.4 | 1.1 | -3.3 | 1.8 | -8.4 |
Other Non Operating Income (Expenses) | 1.2 | 0.4 | 0.2 | 2.4 | 0.3 | 0.2 |
EBT Excluding Unusual Items | 106.6 | 23 | 16.3 | 36.2 | 146.6 | 42.7 |
Merger & Restructuring Charges | -2.9 | -2.9 | -0.7 | -7.2 | -3.2 | -1.5 |
Impairment of Goodwill | -16.4 | - | - | - | - | - |
Gain (Loss) on Sale of Investments | - | - | - | -3.2 | 0.4 | 1.3 |
Gain (Loss) on Sale of Assets | - | - | 7.8 | - | - | - |
Asset Writedown | - | - | 0.2 | -6.3 | - | -5.2 |
Pretax Income | 87.3 | 20.1 | 23.6 | 19.5 | 143.8 | 37.3 |
Income Tax Expense | 24.5 | 5.5 | 5.2 | 5.8 | 37.2 | 10 |
Earnings From Continuing Operations | 62.8 | 14.6 | 18.4 | 13.7 | 106.6 | 27.3 |
Minority Interest in Earnings | 4.5 | 2.1 | -0.8 | -1.9 | -4.8 | -1.5 |
Net Income | 67.3 | 16.7 | 17.6 | 11.8 | 101.8 | 25.8 |
Net Income to Common | 67.3 | 16.7 | 17.6 | 11.8 | 101.8 | 25.8 |
Net Income Growth | 241.62% | -5.11% | 49.15% | -88.41% | 294.57% | 14.67% |
Shares Outstanding (Basic) | 150 | 150 | 149 | 149 | 148 | 142 |
Shares Outstanding (Diluted) | 151 | 150 | 150 | 149 | 148 | 142 |
Shares Change (YoY) | 0.46% | 0.36% | 0.47% | 0.41% | 4.66% | 6.31% |
EPS (Basic) | 0.45 | 0.11 | 0.12 | 0.08 | 0.69 | 0.18 |
EPS (Diluted) | 0.45 | 0.11 | 0.12 | 0.08 | 0.69 | 0.18 |
EPS Growth | 241.81% | -5.48% | 49.16% | -88.48% | 276.93% | 8.33% |
Free Cash Flow | 165.9 | 139.6 | 94.5 | 29.6 | 114.5 | 82.6 |
Free Cash Flow Per Share | 1.10 | 0.93 | 0.63 | 0.20 | 0.77 | 0.58 |
Dividend Per Share | 0.150 | 0.150 | 0.120 | 0.120 | 0.120 | 0.070 |
Dividend Growth | 25.00% | 25.00% | - | - | 71.43% | - |
Gross Margin | 23.01% | 21.43% | 20.58% | 22.52% | 28.68% | 26.48% |
Operating Margin | 7.02% | 3.50% | 3.54% | 4.55% | 11.80% | 6.82% |
Profit Margin | 2.90% | 0.80% | 1.01% | 0.78% | 7.39% | 2.59% |
Free Cash Flow Margin | 7.14% | 6.67% | 5.41% | 1.96% | 8.31% | 8.28% |
EBITDA | 248.1 | 171.2 | 156.3 | 152.7 | 220.6 | 114.4 |
EBITDA Margin | 10.68% | 8.18% | 8.95% | 10.11% | 16.02% | 11.46% |
D&A For EBITDA | 85 | 98 | 94.4 | 84 | 58 | 46.4 |
EBIT | 163.1 | 73.2 | 61.9 | 68.7 | 162.6 | 68 |
EBIT Margin | 7.02% | 3.50% | 3.54% | 4.55% | 11.80% | 6.82% |
Effective Tax Rate | 28.06% | 27.36% | 22.03% | 29.74% | 25.87% | 26.81% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.